What Equifax’s recent share performance tells you

Equifax (EFX) has seen its share price under pressure, with a 12.5% decline year to date and a 19.8% total return decline over the past year, prompting closer attention from investors.

Over the past month, the stock shows a 2.8% decline, widening to a 14.1% total return decline over the past 3 months. These moves contrast with longer term returns, where the past 5 years show a 10.7% total return gain.

At a share price of $187.32, Equifax’s recent 7 day share price return of a 4.4% decline and 90 day share price return of a 14.1% decline contrast with a 5 year total shareholder return of 10.69%, pointing to fading momentum after earlier gains.

If Equifax’s recent weakness has you reassessing your watchlist, this can be a good moment to broaden your search and check out 20 top founder-led companies

With Equifax trading at $187.32, an indicated 52.8% intrinsic discount and a 26.7% gap to the average analyst target raise the key question: is this genuine value, or is the market already factoring in future growth?

Most Popular Narrative: 21.2% Undervalued

Equifax’s fair value in the most followed narrative sits at $237.60 versus a last close of $187.32, putting a clear valuation gap in focus for investors weighing the recent share price weakness.

Accelerating customer adoption of new multi data product solutions (e.g., TWN indicator, Single Data Fabric, EFX.AI) and continued high NPI (New Product Introduction) rates are expanding Equifax's value proposition. This is positioning the company to capture incremental market share and drive sustained organic revenue growth above historical levels. Structural expansion of government verification requirements (e.g., semiannual redeterminations, added work requirements, improper payment focus) and a rising TAM for eligibility verification services are set to benefit long term revenue growth and reduce business cyclicality as Equifax's solutions become more critical to federal and state programs.

Want to see what kind of revenue runway and profit margins are baked into that fair value, and how rich the assumed future earnings multiple really is? The underlying narrative leans heavily on faster earnings growth than the wider market and a premium P/E profile that many investors normally associate with high quality compounders. If you are curious which specific growth, margin and valuation inputs push the model to $237.60, the full narrative lays those assumptions out in black and white.

Result: Fair Value of $237.60 (UNDERVALUED)

However, that story can change quickly if legal costs stay elevated or if tighter state budgets keep government related revenue more volatile than analysts expect.

Another way to look at Equifax’s value

The earlier fair value of $237.60 and a 52.8% discount from the SWS DCF model paint one picture of upside. Yet on earnings, Equifax trades on a P/E of 34.1x versus an industry average of 18.9x, a peer average of 32.5x, and a fair ratio of 31.1x, which suggests investors are already paying a premium for the story.

That gap means there is less room for error if growth or margins come in below expectations. The real question is whether you are comfortable paying above both industry and fair ratio levels for this kind of earnings profile, or whether you would rather wait for the P/E to move closer to the fair ratio.

Next Steps

With sentiment in this article pulled between opportunity and concern, it makes sense to move fast, review the numbers yourself and form your own stance. To weigh up the upside against the potential downsides, take a closer look at the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If Equifax is on your radar, this is also a smart moment to widen your search and line up a few fresh ideas that could suit your approach.

• Spot potential high growth moves early by checking out 33 elite penny stocks with strong financials before the crowd catches on.
• Zero in on opportunities that mix quality with attractive pricing by reviewing the 49 high quality undervalued stocks.
• Prioritise resilience and financial strength by scanning the solid balance sheet and fundamentals stocks screener (42 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.